DreaMS - Validation Study 1

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

March 30, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

March 31, 2027

Conditions
Multiple Sclerosis
Interventions
DEVICE

dreaMS App R2.1

The Healios+Me platform App which contains the dreaMS App will be downloaded by all participants and all participants (PwMS and HC) will follow the same schedule

Trial Locations (6)

Unknown

RECRUITING

Neurozentrum, Kantonsspital Aarau, Aarau

RECRUITING

Department of Neurology, CHUV Lausanne, Lausanne

RECRUITING

Centro Sclerosi Multipla, Ospedale Regionale di Lugano, Lugano

RECRUITING

Klinik für Neurologie, Kantonsspital St. Gallen, Sankt Gallen

RECRUITING

Klinik für Neurologie, Universitätsspital Zürich, Zurich

RECRUITING

MS Center, Department of Neurology University Hospital Basel, Basel

Sponsors
All Listed Sponsors
collaborator

University Hospital, Basel, Switzerland

OTHER

collaborator

University of Basel

OTHER

collaborator

Innosuisse - Swiss Innovation Agency

OTHER

collaborator

Novartis Pharmaceuticals

INDUSTRY

collaborator

Hoffmann-La Roche

INDUSTRY

collaborator

Indivi AG

INDUSTRY

lead

Research Center for Clinical Neuroimmunology and Neuroscience Basel

OTHER